Dmitry Balyasny’s SpringWorks Therapeutics SWTX Stock Holding History

Dmitry Balyasny’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-705,364	Closed	-$33.1M	–	3449
2025 Q2	$33.1M	Buy	705,364 +88,636	+14%	+$3.94M	0.05%	469
2025 Q1	$27.2M	Buy	616,728 +530,967	+619%	+$24.4M	0.05%	487
2024 Q4	$3.1M	Buy	+85,761	New	+$3M	﹤0.01%	1496
2023 Q4	–	Sell	-47,218	Closed	-$1.09M	–	2890
2023 Q3	$1.09M	Buy	+47,218	New	+$1.29M	﹤0.01%	1544
2021 Q2	–	Sell	-22,492	Closed	-$1.66M	–	2330
2021 Q1	$1.66M	Buy	+22,492	New	+$1.76M	0.01%	1091

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Dmitry Balyasny's SWTX Position: Q3 2025 in Review

Dmitry Balyasny sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 705,364 shares — an estimated $33.1M sold.

Dmitry Balyasny first reported a position in SWTX in Q1 2021 and held it in 5 quarters. The position peaked at $33.1M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Dmitry Balyasny reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Dmitry Balyasny sold 705,364 SpringWorks Therapeutics shares in Q3 2025, an estimated $33.1M.
Dmitry Balyasny first reported a position in SpringWorks Therapeutics in Q1 2021 and held it in 5 quarters.
Dmitry Balyasny's SpringWorks Therapeutics position peaked at $33.1M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.